What is Steris?
Founded in 1985 and headquartered in Leicester, United Kingdom, STERIS plc is a recognized global leader specializing in infection prevention, contamination control, and sterilization solutions. The company caters to a diverse clientele, including healthcare providers, pharmaceutical firms, scientific research institutions, industrial entities, and governmental organizations worldwide. STERIS's extensive portfolio encompasses sterilizers, surgical tables, examination lights, operating room equipment, gastrointestinal devices, and advanced cleaning systems. Beyond its product offerings, STERIS provides critical outsourced services to hospitals and healthcare facilities, focusing on equipment maintenance, sterilization management, and operational efficiency consulting. The company's global footprint and its capabilities in contract sterilization utilizing technologies such as gamma radiation, electron beam, X-ray, and ethylene oxide gas, complemented by robust laboratory testing and validation services, solidify its market leadership.
How much funding has Steris raised?
Steris has raised a total of $13M across 1 funding round:
Stock Offering
$13M
Stock Issuance/Offering (1992): $13M, investors not publicly disclosed
What's next for Steris?
The recent major strategic investment in STERIS plc signals a pivotal moment for the company, likely enabling further expansion of its advanced sterilization technologies and infection prevention services. This capital infusion is expected to fuel research and development into next-generation medical devices and contamination control solutions, potentially targeting emerging healthcare challenges and expanding its reach into new international markets. STERIS's strategic focus on enhancing healthcare safety and efficiency positions it for continued growth and innovation in the competitive global medical manufacturing landscape.
See full Steris company page
